KAITLYN JONES: Open Payments
NPI 1285231720 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,262 in 109 payments from 22 companies in 2025. Trend: 2023 $2,415 · 2024 $2,368 · 2025 $2,262
Food & beverage: $2,262
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 20 | $403 |
| Amgen Inc. | 15 | $225 |
| GlaxoSmithKline, LLC. | 11 | $215 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $203 |
| GENZYME CORPORATION | 8 | $186 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $177 |
| Mallinckrodt Hospital Products Inc. | 5 | $113 |
| Vifor Pharma, Inc. | 5 | $110 |
| Grifols USA, LLC | 4 | $90 |
| Viatris Specialty LLC | 3 | $73 |
Products named: TEZSPIRE, DUPIXENT, GLASSIA, OFEV, TRELEGY ELLIPTA, ACTHAR, FASENRA, Zemaira.
Industry payments across AL — which companies pay providers there.
